Ying Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ying Zhu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Ji-Fu Wei
Department of Pharmacy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
3 shared publications - Xiao-Li Tian
Aging and Vascular Diseases, Human Aging Research Institute (HARI) and School of Life Science Nanchang University, and Jiangxi Province Key Laboratory of Aging and Disease Nanchang Jiangxi China
3 shared publications - Jin-Lyu Sun
Department of Allergy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
2 shared publications Xiao-Jing Ling
Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China
2 shared publicationsYiqi Wan
Human Aging Research Institute (HARI) and School of Life Science Nanchang University, and Jiangxi Province Key Laboratory of Aging and Disease Nanchang Jiangxi China
2 shared publicationsZhi-Qiang Xu
Clinical Allergy Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Research Division of Clinical Pharmacology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by Wiley in Aging Cell
- Vol. 25 (1) , e70326
miR ‐375‐3p/ STX6 Exacerbates Atherosclerosis by Promoting Endothelial Cell Senescence via Activation of TGF ‐Beta Signals
Atherosclerosis, a key pathological basis of cardio‐cerebrovascular diseases, is closely associated with aging and endothelial cell senescence. The role of microRNAs (miRNAs) in regulating endothelial cell senescence and atherosclerosis remains incompletely understood. In this study, we discovered that miR‐375‐3p expression was significantly elevated in the serum of both aged and atherosclerotic mice. Overexpression of miR‐375‐3p induced endothelial cell senescence, evidenced by increased senescence‐associated β‐galactosidase (SA‐β‐gal) staining, upregulation of p15, IL6, and IL8, and inhibited cell colony formation. In vivo inhibition of miR‐375‐3p in ApoE −/− mice markedly reduced atherosclerotic plaque formation. We further identified STX6 as a direct target of miR‐375‐3p, and its overexpression rescued the senescence‐related phenotypes induced by miR‐375‐3p. Mechanistically, the miR‐375‐3p/STX6 signaling axis promoted endothelial cell senescence via the SMAD2/p15 pathway in a SMAD2‐dependent manner, and overexpression of STX6 attenuated atherosclerosis progression in mice. Together, our findings highlight the miR‐375‐3p/STX6 axis as a critical regulator of endothelial cell senescence and a potential translational use in the prevention of atherosclerosis and related diseases.
- 10 December 2025
- Published by Wiley in Aging Cell
- Vol. 25 (1) , e70326
Open AccessmiR ‐375‐3p/ STX6 Exacerbates Atherosclerosis by Promoting Endothelial Cell Senescence via Activation of TGF ‐Beta Signals
Atherosclerosis, a key pathological basis of cardio‐cerebrovascular diseases, is closely associated with aging and endothelial cell senescence. The role of microRNAs (miRNAs) in regulating endothelial cell senescence and atherosclerosis remains incompletely understood. In this study, we discovered that miR‐375‐3p expression was significantly elevated in the serum of both aged and atherosclerotic mice. Overexpression of miR‐375‐3p induced endothelial cell senescence, evidenced by increased senescence‐associated β‐galactosidase (SA‐β‐gal) staining, upregulation of p15, IL6, and IL8, and inhibited cell colony formation. In vivo inhibition of miR‐375‐3p in ApoE −/− mice markedly reduced atherosclerotic plaque formation. We further identified STX6 as a direct target of miR‐375‐3p, and its overexpression rescued the senescence‐related phenotypes induced by miR‐375‐3p. Mechanistically, the miR‐375‐3p/STX6 signaling axis promoted endothelial cell senescence via the SMAD2/p15 pathway in a SMAD2‐dependent manner, and overexpression of STX6 attenuated atherosclerosis progression in mice. Together, our findings highlight the miR‐375‐3p/STX6 axis as a critical regulator of endothelial cell senescence and a potential translational use in the prevention of atherosclerosis and related diseases.
- 19 June 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 121, 110495
Aiming to IgE: Drug development in allergic diseases
- 19 June 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 121, 110495
Aiming to IgE: Drug development in allergic diseases
- Open Access
- 10 November 2022
- Published by Elsevier in Allergology International
- Vol. 72 (2) , 347-350
Molecular and immunological characterization of two polcalcins as novel allergens of Artemisia sieversiana pollen
- 10 November 2022
- Published by Elsevier in Allergology International
- Vol. 72 (2) , 347-350
Open AccessMolecular and immunological characterization of two polcalcins as novel allergens of Artemisia sieversiana pollen
- 19 May 2022
- Published by Elsevier in Molecular Immunology
- Vol. 147, 170-179
A new cysteine protease allergen from Ambrosia trifida pollen: proforms and mature forms
- 19 May 2022
- Published by Elsevier in Molecular Immunology
- Vol. 147, 170-179
A new cysteine protease allergen from Ambrosia trifida pollen: proforms and mature forms
- Open Access
- 7 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2879
Hyperglycemia Promotes Endothelial Cell Senescence through AQR/PLAU Signaling Axis
Hyperglycemia is reported to accelerate endothelial cell senescence that contributes to diabetic complications. The underlying mechanism, however, remains elusive. We previously demonstrated AQR as a susceptibility gene for type 2 diabetes mellitus (T2DM) and showed that it was increased in multiple tissues in models with T2DM or metabolic syndrome. This study aimed to investigate the role of AQR in hyperglycemia-induced senescence and its underlying mechanism. Here, we retrieved several datasets of the aging models and found the expression of AQR was increased by high glucose and by aging across species, including C. elegans (whole-body), rat (cardiac tissues), and monkey (blood). we validated the increased AQR expression in senescent human umbilical vein endothelial cells (HUVECs). When overexpressed, AQR promoted the endothelial cell senescence, confirmed by an increased number of cells stained with senescence-associated beta-galactosidase and upregulation of CDKN1A (P21) as well as the prohibited cellular colony formation and G2/M phase arrest. To explore the mechanism by which AQR regulated the cellular senescence, transcriptomic analyses of HUVECs with the overexpression and knockdown of the AQR were performed. We identified 52 co-expressed genes that were enriched, in the terms of plasminogen activation, innate immunity, immunity, and antiviral defense. Among co-expressed genes, PLAU was selected to evaluate its contribution to senescence for its highest strength in the enrichment of the biological process. We demonstrated that the knockdown of PLAU rescued senescence-related phenotypes, endothelial cell activation, and inflammation in models induced by AQR or TNF-α. These findings, for the first time, indicate that AQR/PLAU is a critical signaling axis in the modulation of endothelial cell senescence, revealing a novel link between hyperglycemia and vascular dysfunction. The study may have implications in the prevention of premature vascular aging associated with T2DM.
- 7 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2879
Open AccessHyperglycemia Promotes Endothelial Cell Senescence through AQR/PLAU Signaling Axis
Hyperglycemia is reported to accelerate endothelial cell senescence that contributes to diabetic complications. The underlying mechanism, however, remains elusive. We previously demonstrated AQR as a susceptibility gene for type 2 diabetes mellitus (T2DM) and showed that it was increased in multiple tissues in models with T2DM or metabolic syndrome. This study aimed to investigate the role of AQR in hyperglycemia-induced senescence and its underlying mechanism. Here, we retrieved several datasets of the aging models and found the expression of AQR was increased by high glucose and by aging across species, including C. elegans (whole-body), rat (cardiac tissues), and monkey (blood). we validated the increased AQR expression in senescent human umbilical vein endothelial cells (HUVECs). When overexpressed, AQR promoted the endothelial cell senescence, confirmed by an increased number of cells stained with senescence-associated beta-galactosidase and upregulation of CDKN1A (P21) as well as the prohibited cellular colony formation and G2/M phase arrest. To explore the mechanism by which AQR regulated the cellular senescence, transcriptomic analyses of HUVECs with the overexpression and knockdown of the AQR were performed. We identified 52 co-expressed genes that were enriched, in the terms of plasminogen activation, innate immunity, immunity, and antiviral defense. Among co-expressed genes, PLAU was selected to evaluate its contribution to senescence for its highest strength in the enrichment of the biological process. We demonstrated that the knockdown of PLAU rescued senescence-related phenotypes, endothelial cell activation, and inflammation in models induced by AQR or TNF-α. These findings, for the first time, indicate that AQR/PLAU is a critical signaling axis in the modulation of endothelial cell senescence, revealing a novel link between hyperglycemia and vascular dysfunction. The study may have implications in the prevention of premature vascular aging associated with T2DM.
- Open Access
- 10 November 2021
- Published by Wiley in Transfusion
- Vol. 62 (1) , E3-E4
Identification of a stably inherited novel A subtype with c. 625T >G mutation
- 10 November 2021
- Published by Wiley in Transfusion
- Vol. 62 (1) , E3-E4
Open AccessIdentification of a stably inherited novel A subtype with c. 625T >G mutation
- Open Access
- 18 June 2021
- Published by Association for Computing Machinery (ACM)
- p. 1
Application of Big Data Marketing in Customer Relationship Management
Policy decisions and marketing models have a great impact on the specific application of customer relationship management. In various fields of marketing, big data marketing is gradually popularized as a combined product. The so-called big data marketing refers to collecting a large amount of behavior data through the Internet, primarily helping advertisers find out the target audience to analyze the content, time and form of advertising and finally complete the marketing process of advertising. The big data marketing can also be used for effective customer relationship management, which not only effectively enhance customer stickiness and reduce enterprise operating costs, but also has great significance for deeply mining the potential value of existing customers, predicting the future demand trend of customers, discovering new market growth points and developing new customer groups. Taking the large FMCG company A as the research subject, its sales is grim and stagnant: the purchase quantity of products is low; the price is lower than the cost; simple reproduction is difficult to continue. In order to change the current situation of company A, first of all, we cooperate with the marketing team to determine the business needs, using SQL and python to conduct exploratory data analysis (EDA) on 110k + e-commerce transaction data, and generate Data-Driven Insights on purchasing behavior and product sales; secondly, we use Python to establish RFM model (recent degree, frequency, currency), classify customers and calculate. Finally, according to the above customer analysis, a feasible listing strategy is proposed, which is expected to increase the retention rate by 3.5% and the monthly sales by 6%. Through big data marketing calculation, we come to a solution for the current situation of company A, which will have a good influence on many other companies.
- 18 June 2021
- Published by Association for Computing Machinery (ACM)
- p. 1
Open AccessApplication of Big Data Marketing in Customer Relationship Management
Policy decisions and marketing models have a great impact on the specific application of customer relationship management. In various fields of marketing, big data marketing is gradually popularized as a combined product. The so-called big data marketing refers to collecting a large amount of behavior data through the Internet, primarily helping advertisers find out the target audience to analyze the content, time and form of advertising and finally complete the marketing process of advertising. The big data marketing can also be used for effective customer relationship management, which not only effectively enhance customer stickiness and reduce enterprise operating costs, but also has great significance for deeply mining the potential value of existing customers, predicting the future demand trend of customers, discovering new market growth points and developing new customer groups. Taking the large FMCG company A as the research subject, its sales is grim and stagnant: the purchase quantity of products is low; the price is lower than the cost; simple reproduction is difficult to continue. In order to change the current situation of company A, first of all, we cooperate with the marketing team to determine the business needs, using SQL and python to conduct exploratory data analysis (EDA) on 110k + e-commerce transaction data, and generate Data-Driven Insights on purchasing behavior and product sales; secondly, we use Python to establish RFM model (recent degree, frequency, currency), classify customers and calculate. Finally, according to the above customer analysis, a feasible listing strategy is proposed, which is expected to increase the retention rate by 3.5% and the monthly sales by 6%. Through big data marketing calculation, we come to a solution for the current situation of company A, which will have a good influence on many other companies.
- Open Access
- 11 September 2020
- Published by Wiley in Aging Medicine
- Vol. 3 (3) , 195-204
Allelic distribution of ABO gene in Chinese centenarians
Objective: Human ABO blood groups are determined by the alleles A, B, and O (O01 and O02) of the ABO gene and have been linked to the risks for cardiovascular diseases and cancers that affect lifespan.We examined the genetic associations of the ABO gene and blood groups with longevity.Methods: We inspected the frequencies of the A, B, O, and O02 alleles in a large Chinese centenarian population (n = 2201) and in middle‐aged controls (n = 2330). The single nucleotide polymorphisms were selected as allele A (rs507666), B (rs8176743, rs8176746, and rs8176749), O (rs687289), and O02 (rs688976, rs549446, and rs512770).Results: Supported by allelic and genotypic association studies, the frequencies of blood types A, B, O, and AB in centenarian versus control participants were not statistically different: 0.2821 versus 0.2781 (χ2 = 0.09, P = 0.76), 0.2867 versus 0.3060 (χ2 = 2.03, P = 0.15), 0.3380 versus 0.3159 (χ2 = 2.52, P = 0.11), and 0.0859 versus 0.0910 (χ2 = 0.37, P = 0.54), respectively. Sex had little effect on these distributions.Conclusion: Integrated with other previous reports, we conclude from this large Chinese cohort that genetic variants of the ABO gene and blood groups are not associated with longevity.
- 11 September 2020
- Published by Wiley in Aging Medicine
- Vol. 3 (3) , 195-204
Open AccessAllelic distribution of ABO gene in Chinese centenarians
Objective: Human ABO blood groups are determined by the alleles A, B, and O (O01 and O02) of the ABO gene and have been linked to the risks for cardiovascular diseases and cancers that affect lifespan.We examined the genetic associations of the ABO gene and blood groups with longevity.Methods: We inspected the frequencies of the A, B, O, and O02 alleles in a large Chinese centenarian population (n = 2201) and in middle‐aged controls (n = 2330). The single nucleotide polymorphisms were selected as allele A (rs507666), B (rs8176743, rs8176746, and rs8176749), O (rs687289), and O02 (rs688976, rs549446, and rs512770).Results: Supported by allelic and genotypic association studies, the frequencies of blood types A, B, O, and AB in centenarian versus control participants were not statistically different: 0.2821 versus 0.2781 (χ2 = 0.09, P = 0.76), 0.2867 versus 0.3060 (χ2 = 2.03, P = 0.15), 0.3380 versus 0.3159 (χ2 = 2.52, P = 0.11), and 0.0859 versus 0.0910 (χ2 = 0.37, P = 0.54), respectively. Sex had little effect on these distributions.Conclusion: Integrated with other previous reports, we conclude from this large Chinese cohort that genetic variants of the ABO gene and blood groups are not associated with longevity.